Cargando…

Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study

BACKGROUND: To compare the prognosis of first-line systemic chemotherapy of AS (Albumin-bound paclitaxel and S-1) versus SOX (S-1 and oxaliplatin) regimen in Chinese gastric cancer patients with peritoneal metastasis. METHODS: This was a real-world study of gastric cancer patients with peritoneal me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lingyun, Zhang, Jiayu, Wang, Yan, Li, Wei, Yu, Shan, Li, Qian, Yu, Yiyi, Liu, Tianshu, Cui, Yuehong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199240/ https://www.ncbi.nlm.nih.gov/pubmed/35701768 http://dx.doi.org/10.1186/s12876-022-02369-9

Ejemplares similares

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
por: Cui, Yuehong, et al.
Publicado: (2022)

High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients
por: Wang, Yan, et al.
Publicado: (2020)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen
por: Tang, Cheng, et al.
Publicado: (2018)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)
por: Cui, Yuehong, et al.
Publicado: (2023)

Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression Analysis
por: Zhang, Simeng, et al.
Publicado: (2020)

HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
por: Gronau, Felix, et al.
Publicado: (2022)

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study
por: Li, Wei, et al.
Publicado: (2019)

IntegrinB5 upregulated by HER2 in gastric cancer: a promising biomarker for liver metastasis
por: Li, Qian, et al.
Publicado: (2020)

The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
por: Zhang, Chenghai, et al.
Publicado: (2022)

FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L
por: Yu, Shan, et al.
Publicado: (2016)

Study of SOX combined with intraperitoneal high‐dose paclitaxel in gastric cancer with synchronous peritoneal metastasis: A phase II single‐arm clinical trial
por: Tu, Li, et al.
Publicado: (2022)

Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics
por: Pan, Guoqiang, et al.
Publicado: (2020)

Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients
por: Dai, Xichao, et al.
Publicado: (2016)

Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia
por: Wang, Ming, et al.
Publicado: (2021)

Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study
por: Li, Qian, et al.
Publicado: (2016)

Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer
por: Yonemura, Yutaka, et al.
Publicado: (2012)

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2019)

Analysis of the efficacy and influencing factors of preoperative P‐SOX neoadjuvant chemotherapy regimen for progressive gastric cancer—construction of a clinical prediction model
por: Feng, Long, et al.
Publicado: (2023)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
por: Chen, Jun-Bing, et al.
Publicado: (2022)

Mining the role of angiopoietin‐like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis
por: Tang, Cheng, et al.
Publicado: (2020)

c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Yu, Shan, et al.
Publicado: (2013)

Dual-Energy Computed Tomography-Based Radiomics to Predict Peritoneal Metastasis in Gastric Cancer
por: Chen, Yong, et al.
Publicado: (2021)

Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer
por: Feldbrügge, Linda, et al.
Publicado: (2021)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
por: S.P, Somashekhar, et al.
Publicado: (2021)

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma
por: Tong, Xiwen, et al.
Publicado: (2023)

Editorial: Peritoneal metastasis of gastric cancer
por: Wang, Shuyi, et al.
Publicado: (2023)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
por: Huang, Weicai, et al.
Publicado: (2020)

Maintenance Chemotherapy with S-1 Following SOX Regimen Chemotherapy Improves Prognosis of Stage 3 Gastric Cancer After D2 Gastrectomy: A 5-Year Analysis
por: Tang, Chengwu, et al.
Publicado: (2020)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
por: Zhang, Xin, et al.
Publicado: (2021)

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer
por: QU, YING, et al.
Publicado: (2014)

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

Noninvasive Prediction of Occult Peritoneal Metastasis in Gastric Cancer Using Deep Learning
por: Jiang, Yuming, et al.
Publicado: (2021)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
por: Nadiradze, Giorgi, et al.
Publicado: (2015)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
por: Kim, Dong-Wook, et al.
Publicado: (2018)

Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis
por: Kim, Dong-Wook, et al.
Publicado: (2020)

A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis
por: Tang, Cheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dm5tr5oj5r2360eio1kub5ncip